Fixed-treatment duration venetoclax following covalent BTKi progression in chronic lymphocytic leukemia.
TO THE EDITOR: Covalent Bruton tyrosine kinase inhibitors (cBTKis) are commonly used targeted agents in early lines of therapy for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL); however, treatment following disease progression on cBTKis remains a challenge in clinical practice. Venetoclax is a B-cell lymphoma-2 inhibitor approved for CLL and SLL treatment, either as continuous monotherapy or as a fixed-treatment duration (FTD) regimen in combination with anti-CD20 antibodies (FTD Ven+anti-CD20; frontline, 12 months; relapsed/refractory, 24 months). Venetoclax has demonstrated durable responses and outcomes among patients with previous cBTKi exposure, both in clinical trials (eg, M14 032 and VENICE-1)6,7 and in real-world studies.
Authors
- Frederick Lansigan (ORCID: https://orcid.org/0000-0001-6027-3359)
- Isabelle Fleury (ORCID: https://orcid.org/0000-0002-9301-4748)
- Andrés Chang (ORCID: https://orcid.org/0000-0001-6679-9060)
- Brian Thomas Hill (ORCID: https://orcid.org/0000-0001-8781-3327)
- Nicole Lamanna (ORCID: https://orcid.org/0000-0003-3331-9491)
- Alan Pierre Zausner Skarbnik (ORCID: https://orcid.org/0000-0002-1276-7546)
- Catherine Callaghan Coombs (ORCID: https://orcid.org/0000-0001-5615-2247)
- Deborah Marie Stephens (ORCID: https://orcid.org/0000-0001-9188-5008)
- Nicolás Martínez‐Calle (ORCID: https://orcid.org/0000-0002-5184-9464)
- Lindsey Elizabeth Roeker (ORCID: https://orcid.org/0000-0002-3806-059X)
- Paul M. Barr (ORCID: https://orcid.org/0000-0002-9733-401X)
- Joanna Meehan Rhodes (ORCID: https://orcid.org/0000-0002-5068-9040)
- Matthew Steven Davids (ORCID: https://orcid.org/0000-0003-4529-2003)
- Meghan C. Thompson (ORCID: https://orcid.org/0000-0003-1462-4802)
- Hande H. Tuncer (ORCID: https://orcid.org/0000-0001-8458-9649)
- Beenish S. Manzoor (ORCID: https://orcid.org/0000-0002-0329-3465)
- Christopher Edward Jensen (ORCID: https://orcid.org/0000-0002-6673-335X)
- Bita Fakhri (ORCID: https://orcid.org/0000-0002-2124-7243)
- Jennifer R. Brown
- Mazyar Shadman
- Nilanjan Ghosh
- Laurie Pearson
- Irina PIVNEVA
- Michael Coyle
- Stephen J Schuster
- Chaitra Ujjani
- Yun Choi
- Nnadozie Emechebe
- Wendy Sinai
- Lori A Leslie
- Nancy Kaddis
- Toby A Eyre
- Annie Guerin
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2026-11-17
- DOI
- https://doi.org/10.17615/63cv-5w58
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00